A pharmacist compounds a topical preparation using ingredients obtained from a DEA-registered source but fails to keep a log. Which regulation is primarily violated?
-
A
USP <795> compounding records requirement
-
B
FDCA adulteration provisions
-
C
DEA record-keeping requirements for controlled substance precursors
-
D
OBRA '90 patient counseling standards